Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intiland Development Tbk. (DILD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Intiland Development Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Intiland Development Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intiland Development Tbk. trades at Rp114 (market cap 1.2T, 13.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Intiland Development Tbk. is far larger — about 7.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Intiland Development Tbk. is more actively traded (13.47M versus 187.4K). Which is the better fit depends on your goals.

DILDOBAT
Market Cap
1.2T164.65B
Volume
13.47M187.4K
Lot
134.73K1.87K
Turnover
1.54B44.35M
Average Price
114.29236.67
Value
1.54B44.35M
Indicative Equilibrium Price
114242
Indicative Equilibrium Volume
146500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DILD
View details
OBAT
View details

About Intiland Development Tbk.

PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.

Read more on DILD

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT